Neonatal Hypocalcemia, Neonatal Sepsis
Conditions
Keywords
vitamin D, cord blood, neonatal sepsis, neonatal morbidity
Brief summary
Cholecalciferol (vitamin D3) is a prohormone and its active form is 1,25 dihydroxycholecalciferol. This hormone has effect on both calcium, phosphorus and bone metabolism and also bone morrow, muscle, heart and immune system. For a long time, maternal low vitamin D level is a well known problem for our country and the level was reported as \<10 ng/ml for 46-80% of mothers.The most prominent risk factor was determined as low socioeconomic status. Therefore, the level of 25-hydroxy-vitamin D is supposed to be in relation with several neonatal morbidities and maternal complications of pregnancy.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Term or preterm newborns which are hospitalized in the Neonatal Intensive Care Unit of our hospital
Exclusion criteria
* Preterm babies born before the 24. gestational week * Babies with complex cardiac anomalies and/or dysmorphic features
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| maternal complications of pregnancy | from the beginning of gestation until birth process |
| sepsis | 3 months but patients will be followed until discharge |
| feeding intolerance | 3 months but patients will be followed until discharge |
| hypocalcemia | 3 months but patients will be followed until discharge |
| bronchopulmonary dysplasia | 3 months but patients will be followed until discharge |
| patent ductus arteriosis | 3 months but patients will be followed until discharge |
| retinopathy of prematurity | 3 months but patients will be followed until discharge |
Secondary
| Measure | Time frame |
|---|---|
| rachitism | 4 months but patients will be followed until discharge |